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ABSTRACT 
 
 
Myofibroblasts are activated fibroblasts involved in tissue repair and cancer that are 
characterized by de novo expression of alpha smooth muscle actin (α-SMA), increased 
secretion of growth factors and immunoregolatory fenotype. It is known that 
myofibroblasts form clusters during cancer, fibrotic tissue and wound healing. At the end 
of wound healing, myofibroblasts undergo apoptotic cell death, whereas in vitro 
fibroblasts undergo a necrosis-like programmed cell death, called nemosis, associated 
with inflammatory response.  
As primary myofibroblasts better resemble the tissue environment in vivo, in this work we 
generated spheroids from human primary cutaneous myofibroblasts to evaluate apoptotic or 
necrotic cell death, inflammation and activation markers during myofibroblasts clustering. 
The study showed that spheroid formation does not trigger apoptosis, necrotic cell death 
and cyclooxygenase-2 (COX-2) protein induction associated with inflammatory response. 
The significant decrease of α-SMA in protein extracts of spheroids, compared to 
myofibroblasts monolayer, led to hypothesize that myofibroblasts have undergone a 
deactivation process within spheroids. This hypothesis is supported by cytostatic effect 
exerted by spheroid-conditioned medium on both normal and cancer cell lines, by anti-
migratory effect on normal cells and also by the low number of nuclei positive for the 
proliferation marker Ki-67. The analysis of spheroid reversion to monolayer growth 
demonstrated that fibroblasts cultured as aggregates preserved their proliferation 
capability. Surprisingly, we obtained spontaneous clusters by seeding myofibroblasts on 
plastic and glass substrates: thus the cluster formation could be a physiological feature 
of cutaneous myofibroblasts.  
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This work represents an experimental model to study myofibroblast deactivation and 
highlights the possible relevance of clusters as reservoir of myofibroblasts for regulating 
myofibroblast and tissue turnover. 
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Chapter 1 
INTRODUCTION 
 
1.1 Fibroblasts 
1.1.1 Origins, features and functions 
Human fibroblasts of the adult body represent a heterogeneous population of 
mesenchymal cells, with fusiform and spindle-shaped morphology with several cellular 
processes [1, 2, 3]. They are non-vascular and non-epithelial cells of the connective 
tissue, and are its principal cellular component. Furthermore, fibroblasts are not a 
homogeneous population even within a single tissue and are extremely versatile 
connective tissue cells [4]. In fact, it is known that connective tissue contains a mixture 
of distinct fibroblast lineages, with mature fibroblasts existing side by side with 
immature fibroblasts, often called mesenchymal fibroblasts, that have a remarkable 
capacity to differentiate into other members of the connective tissue family, including 
cartilage, bone, adipocyte and smooth muscle cells [5]. Fibroblasts of each part of the 
body can present different embryonic origins [3]: in fact, according to many authors, head 
and neck cutaneous fibroblasts are generated from the neural crest, hence derive from  
ectoderm, while cutaneous fibroblasts in most of other body regions are considered 
mesodermal cells [6, 7]. Fibroblasts from different sites also show different properties in 
proliferation, collagen synthesis as well as matrix metalloproteinase (MMP) expression 
under basal or inflammatory conditions, in migration and immunomodulatory function 
[89]. These features are maintained by fibroblasts in vitro, even after prolonged culture, 
reflecting their specific identity and positional memory [10]. In particular, fibroblasts 
isolated from different sites reflect a substantial topographic diversity and display distinct 
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and characteristic transcriptional patterns, suggesting that fibroblasts at different locations 
in the body should be considered distinct differentiated cell types [11, 12].  
Fibroblasts can be easily isolated from tissues and cultured in vitro. They can be 
identified based on their fusiform morphology and expression of the fibroblasts specific 
protein-1 (FSP-1), desmin and vimentin, even if these markers are not specific of 
fibroblasts [3, 13]. The important functions of fibroblasts include the production, 
maintenance and renovation of the extracellular matrix (ECM) [13]. Indeed, fibroblasts 
synthesize many of the constituents of ECM, such as collagen type I, III and V and 
fibronectin, maintain ECM homeostasis by regulating ECM turnover and represent an 
important source of ECM degrading proteases such as MMPs. Apart from their function 
in healthy organs, fibroblasts also have a prominent role in remodelling and tissue repair 
and their activation is associated with immune responses [11]. In fact, fibroblasts can also 
acquire an immunoregulatory and activated phenotype triggering and upholding 
inflammation [2, 14]. In particular, fibroblasts modify the quantity, quality, and duration 
of the inflammatory infiltrate and play a critical role in the switch of acute resolving to 
chronic persistent inflammation [15].  
1.1.2 Fibroblast differentiation into myofibroblasts 
Differentiation of fibroblasts into myofibroblasts, i.e. fibroblast activation, is a complex 
process associated with distinct steps (Figure 1). In healthy tissue fibroblasts are 
maintained in an inactive state. During wound healing and in pathological conditions, 
such as inflammation and cancer, they become activated and differentiate into 
myofibroblasts that are morphologically and functionally different from fibroblasts [16]. 
Therefore, in intact and normal tissue, fibroblasts, stress-shielded by the crosslinked 
ECM, contain actin microfilaments into their cortical meshwork and they neither exhibit 
stress fibers nor form adhesion complexes with the extracellular matrix [17, 18], while 
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under mechanical stress, fibroblasts differentiate into proto-myofibroblasts which form 
stress fibers containing β- and γ-cytoplasmic actins [19]. Moreover stress fibers stretch 
between cells via de novo established N-cadherins type adherens juntions and to 
fibronexus adhesion complexes. The fibronexus is a specialized adhesion complex that 
uses transmembrane integrins to link intracellular actin with extracellular fibronectin 
fibrils [17]. Furthermore, proto-myofibroblasts express and organize cellular fibronectin, 
including the ED-A splice variant at the cell surface. 
These features resemble those of fibroblasts that are isolated from various connective 
tissues or organs and placed onto plastic tissue culture dishes, in the presence of foetal 
calf serum [17]. Thereby, fibroblasts in vitro are mechanically activated, acquiring a 
proto-myofibroblast phenotype with stress fibers, focal adhesion and extracellular 
fibronectin fibrils [17, 19]. In particular, fibroblasts produce fibronectin messenger 
RNA, but these transcripts lack the two splice segments ED-A and ED-B [20]. 
However, during wound healing, these segments are included in the fibronectin mRNA 
and lead to de novo expression of ED-A fibronectin in the granulation tissue. 
Fibroblasts produce an ECM that contains cellular fibronectin including the ED-A 
splice variant also on rigid planar substrates [21]. 
Proto-myofibroblasts are always present where there is the need to generate mechanical 
tension and to proceed toward differentiated myofibroblasts, the main producers and 
organizers of extracellular matrix able to restore tissue integrity after injury. Myofibroblasts 
are characterized by de novo expression of alpha-smooth muscle actin (α-SMA), their most 
commonly used molecular marker [22, 23]. In culture, the presence of α-SMA in stress 
fibers confers to the differentiated myofibroblasts at least a twofold stronger contractile 
activity compared with proto-myofibroblasts. Furthermore, myofibroblasts are 
characterized by the presence of a contractile apparatus containing bundles of actin 
9 
 
microfilaments associated with contractile proteins, such as non-muscle myosin, and 
terminating at the myofibroblast surface in the fibronexus [23, 24]. Another characteristic 
of myofibroblasts is that, similarly to smooth muscle cells, they are connected directly to 
each other by specific cell-cell contacts, including adherens and gap junctions [18, 25]. 
The presence of intercellular junctions indicates that myofibroblasts could form 
multicellular contractile units within granulation tissue. In particular, gap junctions are 
composed of plasma membrane hemichannels that contain distinct and functionally 
related proteins called connexins. The connexin most expressed in myofibroblasts is 
connexin 43 [17, 26]. Different stimuli are responsible for the fibroblasts activation, 
including epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and 
fibroblast growth factor-2 (FGF2), which are released from injured epithelial cells and 
infiltrating mononuclear cells, such as monocytes and macrophages [27, 28]. It is known 
that trasforming growth factor β1 (TGF-β1) has a key role in stimulating myofibroblast 
differentiation associated with collagen synthesis by fibroblastic cells [29, 30] and the 
expression of cellular fibronectin, particularly the ED-A splice variant [31]. Additionaly, 
fibroblasts are activated by direct cell-cell communication and contacts with leukocytes 
through adhesion molecules, such as intercellular-adhesion molecule-1 (ICAM-1) or 
vascular-cell adhesion molecule-1 (VCAM-1) [27], and by reactive oxigen species, or 
complement factor C1, as well as by the altered ECM composition [28]. It is also known 
that desmoplasia, i.e. disproportionate formation of the fibrous connective tissue, 
generates mechanical forces that convert fibroblasts to myofibroblasts and induces cancer 
cell growth, invasion, and metastasis. [14, 32 ].  
Fibroblasts activation is associated with production of large amounts of cyclooxygenase-2 
(COX-2) and proinflammatory cytokines, although the extent of fibroblast activation 
depends on the tissue type [2, 6]. The fibroblast activated phenotype, either in wound 
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healing, fibrotic or cancer tissue, is associated with de novo expression of α-SMA, 
increased levels of growth factor secretion and ECM-degrading proteases: this process is 
regulated by inflammation and represents the differentiation of fibroblasts into 
myofibroblasts [33, 34, 35]. Fibroblasts in vivo form clusters in cancer, fibrotic tissue and 
wound healing process [36]. Hovewer, in vivo, at the end of wound healing, activated 
fibroblasts undergo apoptotic cell death [37] (Figure 2). On the contrary, fibroblasts in 
vitro undergo a necrosis-like programmed cell death, called nemosis, associated with 
inflammatory response [2, 38]. In particular, it is known that fibroblasts established from 
neonatal foreskin, when forced to cluster, do not grow but undergo a new pathway of cell 
activation, leading to a massive proinflammatory, proteolytic and growth factor response. 
The activation begins with fibronectin-β1, α5 and αV integrin interaction, in particular 
between the RGD motif of fibronectin and cellular integrin receptors [39], and terminates 
in programmed necrosis-like cell death. Previous studies carried out in vitro also showed 
that clusters of fibroblasts established from neonatal foreskin, named spheroids, are 
activated to produce massive amounts of COX-2, prostaglandins, proinflammatory 
cytokines and growth factors: this process is associated with nemosis, leading to 
spheroids decomposition [38]. Indeed, during nemosis, COX-2 protein is present accross 
the whole spheroid and not only in the centre where nutrient deprivation and hypoxia are 
presumably the highest, demostring that COX-2 induction is not triggered by hypoxia [2]. 
Moreover, it is well known that nemotic fibroblast spheroids stop their growth abruptly 
and after about two days begin to decompose, releasing massive amounts of lactate 
dehydrogenase (LDH), proinflammatory cytochines (IL-1, IL-6), chemokines (RANTES, 
IL-8), and growth factors such as hepatocyte growth factor/scatter factor (HGF/SF), 
involved in the promotion of cellular growth and motility. Additionally, it is also known 
11 
 
that fibroblasts clustered in spheroids are committed early to nemosis [38]. Interestingly, 
a recent work showed that nemosis is a reversible process [16]. 
1.1.3 Wound healing  
Wound healing represents a physiological response to injury, ensuring rapid repair of 
damaged tissues, associated with fibroblast activation (Figure 2). It is a highly regulated 
process of consecutive and overlapping phases: immediately after tissue injury, the blood 
coagulation cascade induces inflammatory cell accumulation and cytokine production and 
the release of various growth factors [40]. Disruption of blood vessels also leads to the 
formation of the blood clot, which is composed of cross-linked fibrin, and of extracellular 
matrix proteins. Apart from providing a barrier against invading microorganisms, the 
blood clot also serves as a matrix for invading cells. Inflammatory cells invade the wound 
tissue and produce proteinases and growth factors that stimulate collagen production and 
initiate the proliferative phase of wound repair. At the wound edge, migration and 
proliferation of keratinocytes support re-epithelialization that involves the replication and 
movement of epidermal cell to reconstituite tissue continuity [40]. It is followed by 
proliferation of dermal fibroblasts in the neighborhood of the wound. These cells 
subsequently migrate into the provisional matrix and deposit large amounts of 
extracellular matrix. Furthermore, wound fibroblasts acquire a contractile phenotype and 
transform into myofibroblasts, a cell type which plays a major role in wound contraction. 
In this proliferative phase, in the wound bed a new tissue is formed, called granulation 
tissue because of the granular appearance of the numerous capillaries led by massive 
angiogenesis [41]. Together, these processes restore tissue integrity and reduce the wound 
size to a permanent scar [17]. In the final maturation phase, the overall numbers of 
fibroblastic cells and vessels are reduced by programmed cell death [42]. It is evident that 
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disturbance of the fine equilibrium between cells, growth factors, and ECM in any of 
these phases will impact on the normal course of healing [40]. 
In many instances, due to mechanisms not yet understood, scarring does not occur even 
despite epithelialization, and granulation tissue evolves into a hypertrophic-scar [43]. 
Wound healing and cancer progression have striking similarities [45]. Tumors have been 
described as “never-healing wounds” [44]. The mechanisms that regulate wound healing 
have been shown to promote transformation and growth of malignant cells [46].   Recently, 
inflammatory processes that occur during normal wound healing have been linked to the 
pathological state of many tumors. Motility is needed for the dissemination from the site of 
primary tumor leading to invasive phenotype [47]. Hence, wound healing studies appear 
useful for evaluating the migratory capability of both normal and cancer cells.  
1.1.4 Cancer associated fibroblasts (CAFs) 
Activated fibroblasts are also found in association with cancer cells, in fact they are 
known as cancer-associated fibroblasts (CAFs) (Figure 3). CAFs, acting in a paracrine 
manner, are important promoters of invasion, tumour growth and progression [48, 49], as 
well as angiogenesis and metastatic process [13, 50, 51]. CAFs represent the most 
prominent cell type within the reactive stroma of many cancers, such as breast, prostate 
and pancreatic carcinoma [52]. In breast cancer, over 80% of CAFs are myofibroblast 
which are phenotipically and epigenetically different than normal dermal fibroblasts. 
Indeed, CAFs are considered a cell population in a permanently activated state, sharing 
similarities with fibroblasts activated during wound healing process [53]. Unlike them, 
CAFs neither revert to a normal phenotype nor undergo apoptosis [14] but, once the 
activating stimulus is attenuated, their presence persists in tumor stroma [17, 54]. The 
irreversible activation of CAFs is due to signaling pathways driven by several factors 
produced mainly by tumor cells and autocrine loops [14]. Several works indicate that 
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CAF activation is a redox-dependent process [14, 55]. Indeed, cancer tissues usually 
contain higher levels of reactive oxygen species (ROS) than normal tissues. Furthermore, 
it is known that ROS can be transferred from cancer cells to fibroblasts. In particular, 
ROS promote conversion of fibroblasts into highly migrating myofibroblasts through 
accumulation of the hypoxia-inducible factor (HIF-1α) trascription factor and the 
CXCL-12 chemokine [56]. CAFs can originate from resident stromal fibroblasts, bone 
marrow-derived fibrocytes or by epithelial/endothelial to mesenchymal transition [52]. 
Various markers are used to detect CAFs in cancer tissue and among these α-SMA is 
the most widely used [54].   
1.2 Three-dimensional cultures 
1.2.1 Three-dimensional versus two-dimensional culture  
Traditional two-dimensional (2D) monolayer culture represents a simplified, reproducible 
and largely available system. Despite these features, it is recognized that plastic or glass 
substrates, commonly used for cell culture, are not representative of the cellular 
environment found in living tissue, due to the absence of the stroma that sustains the 
cellular architecture [57]. Cells grown in 2D monolayer culture lose tissue specific properties 
[58, 59] and thus do not reproduce the structural organization or functional differentiation of 
tissues in vivo [60]. Accordingly, moving from cell monolayers to three-dimensional (3D) 
cultures is motivated by the need to work with models that mimic the functions of living 
tissues. The third dimension bridges the gap between cell culture and tissue. 
3D cell cultures have been widely used in biomedical research since the early decades of this 
century. They are able to investigate aspects of tumor biology and pathophysiology, by 
maintaining a 3D cancer cell arrangement that reflects the in vivo normal and cancer 
tissue situation in relation to cell-cell and cell-ECM interactions and differentiation 
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patterns [61]. Furthermore, 3D cell cultures can be used to study the interactions 
between stromal cells, such as fibroblast, and cancer cells [36]. Therefore, 3D cultures 
could better reflect the in vivo behavior of cells in tumor tissues [62]. One major 
advantage of 3D cell cultures is their well defined geometry, which allows to directly 
relate structure to function of 3D cell cultures and enables theoretical analysis, including 
diffusion fields. [63]. 3D cultures are currently used in a broad range of cell biology 
studies and biomedical research [64], including tumour biology [65], cell adhesion, cell 
migration and epithelial morphogenesis, as well as drug screening [66, 67].  
1.2.2 Spheroids 
The most widely used 3D tissue culture model involves cellular aggregates, called 
spheroids, where cells have a spherical, organised and compact symmetry [57], which 
have been proposed by radiobiologists in 1970. Initially, tumor spheroid cultures were 
applied in experimental radiotherapy, followed by photodynamic treatment, hyperthermia 
and chemotherapy and in preclinical drug evaluation [68, 69, 70]. Cellular spheroids are 
simple 3D systems, which take advantage of the natural tendency of many cell types to 
aggregate [57]. They can be obtained from single cultures or co-cultures, as mono or 
multicellular spheroids (MCS), respectively. 
Multicellular tumor spheroids (MTS) present many of the characteristics of in vivo 
tumors, which are unavailable in monolayer cells, and as such, they have gained 
increasing recognition in biomedical research [71]. MTSs are able to accurately mimic 
some features of solid tumors, such as their spatial architecture, physiological responses, 
secretion of soluble mediators, cell morphology, growth kinetics, gene expression 
patterns, tumor cell invasion and metastasis [63]. Currently, several works describe MTS 
as a tumor model in drug and radiotherapy research. Besides sharing many biological 
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similarities with avascular tumors, MTSs also display elevated resistence to chemo- and 
radio-therapies and produce biochemical response mimicking parental tumors. These 
properties make MTS more predictive of the in vivo therapeutic efficacy [68, 72] and 
drug resistance mechanisms [73, 74]. In addition, MCSs hold great promise to be used as 
building blocks in organ printing for the construction of hybrid artificial organs [75].   
Spheroids can be a useful tool to study the tissue turnover regulated by fibroblasts. In 
fact, it is known that activated fibroblasts form clusters in wound healing process, 
idiopathic pulmonary fibrosis and hypertrophic scars, where cells clusters are formed by 
nodules of myofibroblasts [36, 43]. A recent work detected fibroblast aggregates in the 
dermis at early stages of melanoma development, before metastasis formation, and 
showed a paracrine communication between cancer cells and fibroblasts [76]. However, 
the growth of fibroblasts as spheroids can be associated with conditions where fibroblasts 
lose their contact to connective tissue. Additionaly, fibroblasts can lose their contacts to 
ECM during inflammation, wound healing and cancer [16].   
1.2.3 Techniques for the formation and growth of spheroids 
Up to now, a variety of techniques have been developed for the formation and growth of 
multicellular spheroids [64], in order to obtain cellular aggregation encouraging cell-cell 
contacts and avoiding traditional cell-plastic substrates. A simple and reproducible 
method for generating spheroids is a prerequisite for spheroid-based applications. Among 
the known strategies, the oldest is the “spinner flask” method [77], where cells are 
maintained in spinner flasks and the constant movement prevents their attachment to 
the walls of the flask and allows them to attach to each other and grow as aggregates 
[78] (Figure 4A). Comparable methods use roller tubes, gyratory shakers or rotating 
wall vessels [79] which keep the cell suspension in continuous agitation between 
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rotating cylindrical walls [80] (Figure 4B). Using these culture vessels for spheroids 
production, the spheroid can suffer from a rather strong shear force, which may affect 
cell physiology. To overcome this problem, an improved rotary cell culture system has 
been designed to create a unique microgravity environment with low shear force [80]. 
These methods are suitable for large scale production. However, they have not been used 
by a lot of researches due to their drawbacks, including the generation of numerous 
heterogeneously sized spheroids, the inability to study individual spheroid for prolonged 
periods, the need for large volume of media culture and specialized equipment. 
Other techniques are based on the loss of an appropriate surface for cell attachment that 
might promote MCS formation, just as the constant agitation does in the spinner flask 
system (Figure 4C). The growth of spheroids is feasible over plates made of nonadhesive 
plastics or plates made nonadhesive for cells by coating with a thin nonadherent film. 
Agarose represents one of the most efficient substrates to prevent cell attachment [67, 81], 
followed by hydrophobic polymers, including nonionic compound poly2-
hydroxyethymethacrylate (polyHEMA) [82], which also prevents matrix deposition and 
subsequent cells attachment. The use of nonadherent surfaces for cells frequently yields 
delicate numerous aggregates with highly irregular geometry. Consequently, obtaining 
aggregates of roughly equal size and shape requires manual selection and/or screening [72]. 
Furthermore, effects on the cells due to physical forces or chemicals can not be 
excluded [83]. These methods have also the drawbacks of being tedious, manually 
intensive and with a limited scope for mass production. 
To address many of the problems identified above, tissue engeenering has developed a 
more advanced 3D cancer models using biological gels as a substrate for spheroid growth. 
The earliest attempts to grow cancer cells within 3D substrates use small explants of cancer 
tissue within a natural gel. Because of its ubiquitous nature and relative ease of isolation, 
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collagen is one of the earliest biomaterials to be widely used for 3D cell culture [84]. This 
method is used to culture a wide variety of cancer types in a way that preserves the native 
tissue architecture and cell viability. Other natural polymer gels that have been used are the 
alginate, a natural polymer derived from brown seaweed that gels in the presence of 
calcium ions, and the Matrigel, a basement membrane extract derived from the 
Engelbreth-Holm-Swarm mouse sarcoma [67, 70].  
Spheroids are also produced by the “hanging-drop” method [85, 86] which was first 
applied to the embryonic stem cells that are able to differentiate forming embryoid 
bodies [87, 88] (Figure 4D). In this method, cells are suspended in droplets of medium, 
diluted to the desired cell density, and dispensed onto the lid of a tissue culture dish. 
When the lid is inverted, each drop is held in place by surface tension and cells 
accumulate at the free liquid-air interface falling to the bottom of the drop. This natural 
disposition of cells pushes them to aggregate. Such approach represents an attractive 
alternative for MCS production, because it is simple, highly reproducible, can be applied 
successfully to a wide variety of cell lines and can produce spheroids in short time and of 
a homogeneous size without the need for sieving or manual selection. However, there are 
several disadvantages of the hanging-drop method: the liquid volume of a drop is limited 
to less than 30 μl, a direct microscopic observation of forming drops is difficult during 
cultivation and, in particular, the inability to change the medium culture make the 
technique suitable only for short-term experiments [89]. For a lot of applications it is 
important that generated spheroids are uniform in shape and size [75, 90]. In order to 
control spheroids size and geometry and to have their massive production, many authors 
used microstructures to guide the multicellular self-assembly; the most widely exploited 
are “microwells” [91] (Figure 4E). Microwells of defined size and different geometry can 
be fabricated by microfabrication techniques such as micromolding of cell-nonadhesive 
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inert materials like agarose or polyethylene glycol (PEG) [92, 93]. Suspended cells are 
loaded onto the fabricated device, redistribuited by gravity and hydrodynamic forces, and 
eventually assembled into aggregates according to microwell geometry. This method has 
some limits, as the complicated fabrication of the microstructures requires specialized 
facilities and the use of a template and specific cell culture plates. 
Recently, Zhao et al. showed that the poly (2-hydroxyethyl methacrylate) PHEMA 
hydrogel film with swelling-induced wrinkling surface pattern can be used for MCS 
generation [94] (Figure 4F). Unlike previously reported studies, the patterned hydrogel 
films were generated spontaneously without the use of any template or specialized 
facilities, directly in the wells of commercial cell culture plates and were able to guide the 
self-assembly of cells. Swelling of the film in water produces various wrinkling patterns 
composed of uniformed microcaves on the film surfaces. When cell suspension is added, 
the cells settle down by gravity to the bottom, accumulate to the center of the microcaves 
and gradually self-assemble into MCSs. Thousands of the spheroids can be generated in a 
single well, with uniform size that can be controlled by the number of cells seeded. 
Despite the existence of various tecniques that can potentially facilitate MCS formation, 
there is currently no standard method to apply for every use. Hence, the research and the 
choice of the suitable method depend on the cell type used and on the scope of the study. 
Often, the available methods need to be combined for obtaining the MCS with the 
required characteristics. Fortunately, MCS-based 3D culture models continue to advance 
in all aspects, including methodology in generation and manipulation of spheroids in 
order to totally satisfy all needs. 
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Chapter 2 
AIM OF WORK 
 
The activation of fibroblasts is represented by their differentiation into myofibroblasts, a 
process characterized by the expression of α-SMA, increased levels of growth factors and 
ECM-degrading proteases. Clusters of activated fibroblasts have been observed in 
physiological and pathological conditions such as wound healing process, idiopathic 
pulmonary fibrosis, hypertrophic scars and cancer [36, 43]. In particular, a recent study 
detected fibroblast aggregates in the dermis at the early stages of melanoma development, 
before metastasis formation, and showed a paracrine communication between cancer cells 
and fibroblasts [76]. The turnover of activated fibroblasts is in vivo associated with 
apoptotic cell death, whereas in vitro, fibroblasts undergo a necrosis-like programmed 
cell death, called nemosis, associated with inflammatory response [37]. 
The aim of the work was to produce and analyze clusters, called spheroids, of human 
primary myofibroblasts from normal skin of neck. Primary myofibroblasts have been 
chosen for the generation of spheroids, as they should better recall the in vivo tissue 
properties, as opposed to the estabilished cell lines used by several other research groups. 
The first goal of the evaluation was to determine the type of cell death, apoptotic or 
nemotic, in order to understand how the activated fibroblasts are regulated following 
spheroids formation; further analyses included the evalutation of the inflammation and 
activation markers, in order to define whether the myofibroblasts within spheroids in vitro 
are quiescent or activated. 
Myofibroblast are involved in the response to injury in physiologial and pathological 
conditions. As such, they have a prominent role in the progression, growth and spread of 
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tumours. Given these premises, it has been considered important to analyze also the 
paracrine interaction between spheroids and both normal and cancer cells. Finally, we 
evaluated the possibility of reversion of spheroids to monolayer growth in vitro. 
By providing the answers to the above questions and determining the features of the 
myofibroblasts in vitro, the present study should further our knowledge on fibroblast 
contribution to the organ architecture in physiological and pathological conditions In 
particular, it could represent an experimental system to study fibroblast 
activation/deactivation process, with a possible application in modulation of unwanted 
tumor progression and massive myofibroblast persistence in connective tissue diseases. 
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Chapter 3 
MATERIALS AND METHODS 
 
3.1 Cutaneous tissues 
Normal human skin specimens were obtained from donors ( n:7 females, mean age 48 ± 
2.5 years) undergoing neck surgery for benign pathologies. Patients with metabolic and 
connective tissue diseases were excluded. The investigation was in agreement with the 
principles outlined in the Declaration of Helsinki [95] and informed consent from all 
patients was obtained. 
3.2 Isolation of primary cutaneous fibroblasts and cell cultures  
Human cutaneous fibroblasts were obtained by using an explant technique. The surgical 
tissue was minced into small fragments (< 1mm) that were washed, placed into 35-mm 
Petri dishes (BD Falcon, Bedford, Massachusetts, USA) and covered with covering 
glasses and grown in Dulbecco’s minimal essential medium (DMEM) (Sigma-Aldrich, 
Saint Louis, Missouri, USA), supplemented with 10% fetal bovine serum (FBS) (GIBCO, 
Grand Island, New York, USA), 200mM L-glutamine, antibiotics (100 mg/ml penicillin, 
100 mg/ml streptomycin) (all purchased by Sigma-Aldrich). The plates were maintained 
at 37°C with 5% CO2 and 95% humidity in a HeraCel (Heracus) incubator, with fresh 
culture medium changed every 3 days. The time required for fibroblast cells outgrowth 
from bioptic fragments was highly variable, usually it took around two weeks. At 75% 
cell confluence, fragments were removed while cells were detached by mild 
trypsinization with 0.25% trypsin-EDTA (Sigma-Aldrich) for 5 min at 37°C, and 
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replated, thereby promoting fibroblasts isolation. All experiments were performed using 
cells only from early passage, within the eighth passages.  
The human keratynocyte (HaCat) and fibrosarcoma (HT1080) cell lines were kindly 
provided by CEINGE (Naples, Italy). Both cell lines were cultured in DMEM under the 
same conditions, as described above. Cells were observed with a phase contrast 
microscope Olympus CKX41 model and the images were acquired with a camera 
connected to its by means Cell-A software.  
3.3 Immunofluorescence analysis of fibroblasts 
Morphological analysis of fibroblasts was performed by plating 5 x 10
4 
cells on glass 
coverslips (Bio-Optica, Milan, Italy). Once adherent cells were more than 75% confluent, 
they were washed in 1X PBS, fixed in 4% paraformaldehyde (Merk Millipore, Billerica, 
Massachusetts, USA) for 20 minutes at room temperature and at least washed again, 
according to standard techniques. Then cells were permeabilized with 0.1% Triton X-100 
(VWR International Srl, Milan, Italy) and blocked in donkey serum (Merk Millipore) 
diluited 1:10 in 1X PBS, for 30 min at room temperature. Glass coverslips (Bio-Optica) 
were incubated for 1 hour at 37°C, with primary antibody against mouse monoclonal 
vimentin (Sigma Aldrich) diluited 1:80. After three washes in PBS, the cells were 
incubated with fluorescein-conjugated donkey anti-mouse secondary antibody (Jackson 
ImmunoResearch Europe, Newmarket, UK) diluted 1:50. F-actin was stained with 
rhodamine phalloidin (Sigma-Aldrich) diluted 1:100 for 1 hour at 37°C. Nuclei were 
counterstained with DAPI (Merck Millipore). Glass coverslips were mounted in 
Vectashield (Vector Labs, Peterborough, UK). Microscopic analysis was performed 
with a Leica DMLB microscope equipped with epifluorescence EL6000 system (Leica 
Microsystems, Wetzlar, Germany). Pictures were taken with digital camera (Leica 
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DFC345FX) connected to the microscope and then merged with the software Leica 
Application Suite. 
3.4 Spheroid cultures 
3.4.1 Generation and growth  
Human primary fibroblasts spheroids were produced adapting the previously described 
hanging-drops and coated plates methods [96]. Fibroblasts were detached from culture 
dishes by trypsin/EDTA (Sigma-Aldrich), harvested, diluted and 20µl of cell-suspension 
drops, containing 1 x 10
4
 cells, were put on lids of 96-well plates (BD Falcon) and the 
tray was inverted. Moreover, into each of the wells were added 100 µl of 1X PBS to 
avoid culture medium evaporation. After 12h of incubation at 37°C, the drops were 
transferred to agar-coated U-bottom 96-well plates (BD Falcon), containing 80µl of 
DMEM. For agar coating, the U-bottom 96-well plates were pre-treated with 1% agarose 
(Applichem, Gatersleben, Saxony-Anhalt, Germany) dissolved in 1X PBS, autoclaved 
and dispensed into each well (100 µl/well) and let to solidify, in order to form a thin film 
of a nonadhesive surface. The formation of the fibroblast spheroids was observed at a 
phase contrast microscope and photographed at 24h, 48h, 72h and 96h after plating. 
The size of the single spheroids was estimated by measuring two orthogonal diameters     
(d1 and d2) using Cell-A software. Spheroid volume was determined according to the 
formula: V=4/3πr3 where r= 1/2 21xdd [96]. Mean diameters and mean volumes were 
calculated for each timepoint. 
Spontaneous spheroids were obtained from 5 x 10
4 
cells seeded onto the bottom of 12-well 
plastic plates (BD Falcon) or glass plates (MatTek corporation, Avenue-Ashland, 
Massachusetts, USA) and maintained in culture for several days. 
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3.4.2 Embedding, sectioning and deparaffinizing  
Spheroids were collected at 24h, 48h, 72h and 96h, fixed in 10% neutral buffered 
formalin (Bio-Optica) and embedded in paraffin (Bio-Optica), according to the standard 
protocol. Serial 4µm-thick sections were obtained by a Leica Supernova ultramicrotome 
and placed on poly-L-lysine coated glass slides (Menzel-Glaser, Brunswick, Germany). 
Slides were deparaffinized twice in xylene and rehydrated in graded series of ethanol, and 
immersed in 10 mM citric acid (Sigma-Aldrich), pH 6, in a microwave oven (VWR) for 
three cycles of 5 minutes at 650 Watt, to exclude epitope masking owing to fixation. This 
procedure was performed before proceeding to every subsequent staining. 
3.4.3 Histochemical and immunohistochemical staining 
Spheroids deparaffinized sections were stained, for morphological analysis, with 
haematoxylin and eosin (Bio-Optica) according to the manufacturer’s protocol. Other 
deparaffinized sections were immunostained with primary antibodies against mouse 
monoclonal vimentin or rabbit monoclonal Ki-67 (both Ventana Medical System, 
Tucson, Arizona, USA) detected by ULTRA View UNIVERSAL DAB DETECTION 
KIT (Ventana Medical Systems), diluted 1:100, according to the manufacturer’s protocol. 
Glass coverslips were always mounted with BioMount (Bio-Optica). Microscopy analysis 
was performed with a Leica DMLB microscope. Images were captured in bright field 
with a digital camera Leica DC200 (Leica Microsystems) connected to the microscope. 
3.4.4 TUNEL assay 
A method for examining apoptosis via DNA fragmentation is by the terminal 
deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) assay [97]. 
TUNEL staining was performed on spheroids sections, deparaffinized and rehydrated as 
described above, using ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit (Merck 
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Millipore), in accordance with the manufacturer’s protocol. In brief, sections were covered 
with terminal deoxynucleotidyl transferase working solution and incubated for 1 hour at 37°C 
in a humidified chamber. The reaction was stopped by incubation with stop/wash buffer. 
After three washes with PBS, antidigoxigenin fluorescein isothiocyanate was applied to the 
slides for 30 minutes at room temperature. Cell nuclei were counterstained with DAPI and   
the stained area of sections were washed in PBS and mounted under a glass coverslip in 
Vectashield (Vector Labs). Microscopic analysis was performed with a Leica DMLB 
microscope equipped with epifluorescence EL6000 system (Leica Microsystems). Pictures 
were taken with digital camera connected to the microscope (Leica DFC345FX) and then 
merged with the software Leica Application Suite. Number of nuclei was calculated using 
Image J software with Cell Counter plugin. The ratio of apoptotic cells was expressed as 
a percentage of positive cells among all cells in a spheroid at each timepoint. 
3.4.5 LDH assay 
The cytotoxicity and cell decomposition in the culture media were evaluated by lactate 
dehydrogenase (LDH) enzymatic activity assay. To this aim, cutaneous myofibroblasts 
seeded at 1 x 10
4
 cells/well were grown as monolayer or spheroid cultures. At selected 
time points, the aliquots of cell-conditioned medium were added to 1ml of the reaction 
mixture containing 0.1M Tris-HCl, pH 7.5, and 125μM NADH. The reaction started with 
the addition of 600μM sodium pyruvate and was followed by the decrease in absorbance 
at 340 nm. The results were normalized to the LDH activity in 100% death caused by 
fibroblast freezing and thawing.  
3.4.6 Protein extraction and Western blotting analysis 
Total protein extracts were prepared from fibroblasts monolayer, harvested by 
tripsin/EDTA, and from fibroblasts spheroids collected at 24h, 48h, 72h and 96h. 
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Samples were incubated on ice-cold for 30 min in a RIPA lysis buffer containing 50mM 
Tris-HCl (pH 7.4), 150mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1mM 
NaF and 1mM Na3VO4, supplemented with proteases inhibitors cocktails (1mM DTT, 
2mM PMSF, 2µg/ml aprotinin and 10µg/ml leupeptin) (Roche Diagnostics Corporation, 
Mannheim, Germany). Lysates were centrifuged at 12000g for 30 min at 4°C and protein 
concentration in the supernatants was determined by the Bradford method (Bio-Rad 
Laboratories, Hercules, California, USA) [98]. Albumin from bovine serum (BSA, Sigma-
Aldrich) was used to construct the standard curve. The absorbances were read by Cary 
Eclipse spectrophotometer (Varian, Santa Clara, California, USA) at 595 nm. Western 
blotting was performed with equal amounts of total protein extracts (20µg). Briefly, protein 
samples were dissolved in SDS-sample buffer and were size-fractionated by electrophoresis 
on 10% SDS-polyacrylamide gel, under reducing and denaturing conditions at 120V and 
transferred onto a polyvinylidene difluoride (PVDF) membrane (Merck Millipore) at 
360mA for 90 minutes. Molecular weight marker was loaded onto gel as a weight 
indicator. The membranes were blocked and then incubated for 1 hour with one of the 
following antibodies: COX-2 (Sigma Aldrich), α-SMA (Abcam, Cambridge, UK), GAPDH 
for loading control (Cell Signaling Technology, Massachusetts, USA), all diluted 1:1000, 
followed by horseradish peroxidase-labelled specific secondary IgG antibodies (all from 
Santa Cruz Biotechnology, Santa Cruz, California, USA) 1:15000 for another 1 hour at 
room temperature. Antibody binding was analysed by an enhanced chemiluminescence 
reaction, using Super Signal West Femto Maximum Sensitivity Substrate Kit (Thermo 
Scientific, Rockford, Illinois, USA) according to the manufacturer’s instructions and 
visualized by autoradiography (Kodak Company, Rochester, New York, USA). Images 
were  acquired by Epson Perfection 2480 Photo (Epson, Suwa, Japan). The intensity of 
individual bands was determined using ImageJ software.  
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3.4.7 MTT assay 
To evaluate the influence of the culture medium conditioned by the fibroblast primary 
spheroids and monolayer on the proliferation of the normal HaCat and cancer HT1080 
cells, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell 
proliferation assay was used. The MTT is an indicator of cell viability and the assay was 
performed according to manufacturer’s protocol. Conditioned medium was prepared by 
culturing cutaneous fibroblasts (1 x 10
4
) in DMEM, grown as monolayer and spheroid 
cultures, and collected at 72h. HaCat and HT1080 cells were seeded on 96-well plates 
(1 x 10
4
). After 24 hours, the culture medium was replaced with 100µl of conditioned 
medium from spheroid or monolayer cultures of fibroblasts. After 48h of incubation, 
10µl of 12mM MTT reagent (5mg/ml, Sigma-Aldrich) was added to each well and 
incubated for 3 hours at 37°C in 5% CO2 incubator. Then, culture medium was removed 
and 100µl of solubilization solution (0.01M HCl in isopropanol) was added to each well 
to dissolve the formazan crystals. Absorbances was measured at 540 nm using Multiscan 
EX microplate reader (Thermo Labsystems, Vantaa, Finland). 
3.4.8 Wound healing assay 
Spheroid- and monolayer-derived conditioned medium, both preparated as described 
above, was used to evaluate the migratory response of HaCat and HT1080 cells in the 
wound healing assay. It is a simple and reproducible method commonly used to assess 
cell motility into the wound space [99]. To this aim, 2,5 x 10
5
 cells were seeded into 
35mm tissue culture plates and were grown to confluence. Then, the confluent monolayer 
of cells was carefully scratched with a sterilized pipette tip. After wounding, the plates 
were rinsed twice with 1X PBS to remove cell debris. Cells were incubated with either 
spheroid- or monolayer-conditioned medium collected after 72 hours of culture. 
Photographs of the same fields were taken at 0h, 4h and 24h with a camera connected to a 
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phase contrast microscope Olympus CKX41 model and the images were acquired using 
Cell-A software. Quantitative analysis of open wound was performed by measuring the 
gap area at different timepoints using ImageJ Software (National Institute of Health, 
USA). The ratio between the relative open surface area at indicated timepoints and at 
baseline was calculated.  
3.4.9 ELISA analysis  
Identical aliquots of fibroblasts (1 x 10
4
) were simultaneously cultured as monolayer and 
multicellular clusters, as previously described, and the conditioned medium was collected 
at 72h to evaluate the secretion of HGF by the cells in vitro. The concentration of HGF 
was estimated by Enzyme-linked immunosorbent assay (ELISA), using Human HGF kit 
(RayBiotech, Norcross, GA) in accordance with manufacturer’s instructions. This assay 
employs an antibody specific for human HGF coated on a 96-well plates. Standards and 
samples were pipetted into the wells and HGF was bound to the wells by the immobilized 
antibody. The wells were washed and biotinylated anti-human HGF antibody was added. 
After washing away unbound biotinylated antibody, HRP-conjugated streptavidin was 
pipetted to the wells. The wells were again washed, a TMB substrate solution was added to 
the wells and color developed in proportion to the amount of bounded HGF. The Stop 
Solution changed the color from blue to yellow, and the absorbance at 450 nm was 
determined using a spectrophotometer Multiscan EX microplate reader (Thermo 
Labsystems). The concentration of HGF was calculated from the standard curves. 
3.5 Reversion of spheroids to adhesion and monolayer growth  
3.5.1 Preparation 
Multicellular aggregates were photographed and then collected from agar-coated U-bottom 
96-well plates after 96 h and 216 h of tridimensional culture and cultured in 60-mm 
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standard plastic dishes (BD Falcon) or on glass coverslips (Bio-Optica). In order to test 
the possible outgrowth of fibroblasts from spheroids and to evaluate the reversion of 
spheroids to adhesion and monolayer growth, spheroids were observed daily. 
3.5.2 Cell cycle analysis  
First, cell cycle of cells outgrown from spheroids cultured for 96 h and 216 h on agar and 
reverted to adhesion growth for twelve days were analyzed with the Cell-Clock 
Mammalian Cell Cycle Assay (Biocolor, North Irland, UK), performed according to the 
manufacturer’s protocol. This assay is a live-cell detection employed to monitor the 
different phases of cell cycle during in vitro culture. It uses the one-hour incubation at 
37°C with a redox dye that is taken up by live cells and undergoes a distinct color 
change. In particular, it is yellow in the reduced form, green in the intermediate state, 
and turns blue in the fully oxidised form; these color changes indicate cells in the G1, 
G2 and M phases, respectively. 
Cells were observed at a  Leica DMLB microscope (Leica Microsystems). Images were 
taken within 15 min from the end of staining procedure in bright field with a digital 
camera (Leica DC200; Leica Microsystems) connected to the microscope. 
3.5.3 Immunofluorescence analysis 
Spheroids cultured for 96 h and 216 h on agar as tridimensional culture and reverted to 
adhesion growth for twelve days were fixed with 4% paraformaldehyde (Merk Millipore), 
washed twice in 50mM NH4Cl, and permeabilized as previously described [100] Double 
immunostaining was performed using a primary mouse vimentin antibody (Sigma-Aldrich) 
and rhodamine phalloidin, as described in paragraph 3.3. Nuclei were stained with DAPI. 
Immunofluorescence analysis was performed with a confocal laser scanning microscope 
LSM 700 (Zeiss, Gottingen, Germany). Fluorescence emission was revealed by 460-489 
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band pass filter for DAPI; 505-530 band pass filter for FITC, and by 560–615 band 
pass filter for TRITC. Triple staining immunofluorescence images were acquired 
separately in the green, red, and UV channels at a resolution of 102 x 1024 pixels, with 
the confocal pinhole set to one Airy unit, and then saved in TIFF format.  
3.5.4 Protein extraction and Western blotting analysis 
The expression of α-SMA was evaluated in the spheroids cultured for 96 h and 216 h on 
agar and for those cultured for 96 h and 216 h on agar and reverted to adhesion growth 
for twelve days. Cell collection, total protein extraction and Western blotting were 
performed as described in the paragraph 3.4.6. GAPDH was used as loading control. 
 
3.6 Statistical analysis 
All numerical data are presented as mean±SEM and were reported in Kaleida Grafh 4.0. 
Statistical differences between groups were evaluated with Student’s two-tailed 
unpaired t-test; p< 0.05 was considered significant. For multiple comparisons, data 
were analyzed with one-way ANOVA with Bonferroni corrections. If not specified 
differently, data shown represent the means of three independent experiments. 
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Chapter 4 
RESULTS 
 
4.1 Analysis of primary cells from skin of neck 
We have first carried out the morphological analysis of cells obtained from normal skin 
of neck, as reported in Material and Methods. To this aim, the presence of intermediate 
filaments and stress fibers was evaluated in monolayer cells by vimentin 
immunofluorescence and phalloidin staining, respectively (Figure 5). The analysis 
revealed the presence of vimentin intermediate filaments and stress fibers, which are 
cytoskeletal markers of mesenchymal cells such as proto-myofibroblasts [17], in the 
spindle-shaped cells. These cells were successively used for the preparation of spheroids. 
4.2 Fibroblast three-dimensional cultures  
4.2.1 Preparation  
To begin with, we attempted to optimize standard techniques in order to ensure the 
formation of spheroids that are homogeneous in size at each different timepoint and that 
can be easily cultivated and finally collected for long-term experiments. For this aim, we 
have adapted the hanging-drops and agarose-coated U-bottom multi-well plates methods to 
generate spheroids (Figure 6A) [96]. Following the seeding, fibroblast aggregates formed 
after 24h of incubation, even if homogeneously sized 3D-spheroids with final tight form 
were seen only after 48h (Figure 6B). Spheroid diameters were thus measured at 48h and 
96h. The values at 48 h ranged from 471 µm to 528 µm with a mean volume of 0.065 
mm
3 
± 0.004; at 72 h from 447 µm to 489 µm, with a mean volume of 0.053 mm
3 
± 
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0.003; at 96 h from 426 µm to 446 µm  with a mean volume of 0.043 mm
3 
± 0.003. The 
volume of spheroids during their maturation decreased significantly after 96 h, possibly 
due to a compaction process. Indeed, with time, spheroids did not undergo a 
decomposition process and became more compact.  
4.2.2 Vimentin immunohistochemical analysis 
Immunohistochemical analysis of paraffin-embedded sections of spheroids collected at 
different times showed positivity for vimentin in all spheroids (Figure 7). These results 
demonstrated that spheroids collected at the different time points are formed by cells 
preserving their mesenchymal origin [101, 102]. 
4.2.3 Evaluation of apoptotic cell death  
DNA fragmentation represents a characteristic hallmark of apoptosis that can be evaluate 
by the TUNEL assay. The DNA strand breaks are detected by enzymatically labeling the 
free 3’-OH termini with modified nucleotides [103]. These new DNA ends are typically 
localized in identifiable nuclei and apoptotic bodies. In contrast, normal or proliferative 
nuclei usually are not stained as they contain insignificant numbers of DNA 3’-OH ends 
TUNEL was performed on sectioned spheroids collected at different times, to evaluate if 
the forcing of adherent cells, such as fibroblasts, to grow as multicellular aggregates 
could trigger apoptotic cell death (Figure 8). The analysis evidenced only few nuclei 
positive for DNA strand breaks at all time points (2,3 % at 24 h, 1,7 % at 48 h, 0,5 % at 
72 h and 0,2 % at 96 h). These results demonstrated that fibroblast clustering did not 
induce a massive apoptotic cell death.  
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4.2.4 Evaluation of necrosis markers  
Haematoxylin and eosin staining was performed to evaluate the presence of necrosis 
based on the typically increased eosinophilia of the necrotic cells. The analysis did not 
detect any evident necrotic area in spheroids collected at different timepoints (Figure 9). 
It is well known that during necrosis, loss of membrane integrity leads to cellular LDH 
release [38]; hence, we measured LDH enzymatic activity in conditioned media from 
fibroblasts grown either as monolayers or as spheroids, collected at indicated time points 
(Figure 10). Marginal levels and the comparable LDH activity were observed in 
conditioned media of both cultures. In particular, a significant increase of LDH activity 
was detected only after 96h of culture in the conditioned medium from both types of 
fibroblast culture, more evident in monolayer-conditioned medium. 
4.2.5 Evaluation of inflammation and activation markers 
To evaluate the levels of inflammation and activation markers specific of fibroblasts 
clustering and activation [38, 104], the levels of COX-2 and α-SMA proteins were 
analyzed in extracts of cells grown in monolayer and in spheroids collected at         
different timepoints. 
Western blot analysis showed both the absence of COX-2 protein induction and the 
time dependent reduction of α-SMA levels in spheroid protein extracts (Figure 11A). In 
particular, the densitometric analysis demonstrated a time-dependent decrease of α-SMA 
levels starting at 48 h and becoming even more evident at 72 and 96h (Figure 11B). This 
decrease of the specific myofibroblast marker α-SMA in spheroids suggests that 
myofibroblasts underwent a deactivation process during spheroid formation. Furthermore, 
the expression of α-SMA in monolayer cell protein extracts (Figure 11B) together with the 
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presence of vimentin intermediate filaments and stress fibers (Figure 5B), previously 
shown, demonstrated that fibroblasts cultured as monolayer are myofibroblasts [17].   
It is known that activated fibroblasts enhance the proliferation and motility of normal and 
cancer cells through paracrine interactions [105]. Therefore, the viability and migratory 
capability of non-tumorigenic keratinocyte (HaCat) and fibrosarcoma metastatic 
(HT1080) cell lines treated with either monolayer- or spheroid-conditioned medium were 
analysed by MTT and scratch wound assay, respectively [106]. The MTT assay showed 
that the viability of both cell lines incubated with spheroid-derived conditioned medium 
was lower when compared with cells treated with monolayer culture-conditioned 
medium (Figure 12). In particular, HaCat and HT1080 cell lines showed a reduction in 
cell viability of about 32% and 25%, respectively.  
As shown in figure 13, the wound healing ability of HaCat cells treated with spheroid-
conditioned medium was dramatically reduced compared to that observed in the same 
cells treated with monolayer-conditioned medium. In particular, at 24h after wounding, 
the quantitative analysis indicated a percentage of open surface area in HaCat culture 
containing spheroid-conditioned medium of about 44%. Conversely, at the same 
timepoint, in HaCat culture treated with monolayer-conditioned medium the scratch area 
was completely closed. On the other hand, HT1080 cells treated either with monolayer or 
spheroid conditioned medium showed a similar migratory capability, as the scratch 
wound was closed within 24h (Figure 14). Only in one of the three independent 
experiments, the wound was still opened, and it contributed to an elevated standard error 
in quantitative analysis. Hence, further experiments will be needed to better understand 
wound healing capability of HT1080 cells. The results of this experiment also suggested 
a noteworthy inhibitory effect of spheroid-conditioned medium on the growth of HT1080 
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cells. Taken together, these data indicate that myofibroblasts underwent a deactivation 
process in the spheroids. 
Previous works showed that myofibroblastic activated phenotype is associated with 
increased secretion of growth factors, such as HGF [107], that support the proliferation 
and migration of normal and tumorigenic cells [2, 33, 44]. In our study, no significant 
differences in HGF concentration were detected between myofibroblast spheroids- and 
monolayers-conditioned medium, as evaluated by ELISA assay (not shown). Hence, the 
observed differences in cell survival and migration seem to be not dependent on HGF, 
even if further studies will be useful to clarify this issue. 
4.2.6 Cell growth fraction evaluation 
Ki-67 is a widely used cellular marker of proliferation and its expression was analyzed by 
immunohistochemistry on paraffin-embedded sections of spheroids collected at different 
timepoints (Figure 15). The analysis revealed the presence of about 6% of nuclei positive 
for Ki-67 in spheroids collected at 24h. It is important to specify that Ki-67 
immunostaining, in all sections tested, did not localize in a restricted area but was evident 
in the centre as well as in the peripheral areas of the spheroids. At 48 hours, there were 
less than 1% of Ki67-positive nuclei and there were no positive cells after this time point. 
4.3 Reversion of spheroids to adhesion and monolayer growth 
Spheroids grown on agar for 96h and 216h were transferred to standard culture dishes or 
glass coverslips, to allow cell adhesion and spreading and to analyse spheroids during 
possible reversion to monolayer growth. This analysis demonstrated that spheroids can 
revert to monolayer growth (Figure 16). 
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4.3.1 Evaluation of cell cycle phases 
A live cell detection colorimetric assay was used to evaluate cell cycle phases of 
monolayer cells derived from spheroids. This analysis showed that monolayer cells from 
spheroids collected at 96 h were in G0/G1, S, or G2/M phases (Figure 16A). In the 
population of monolayer cells from spheroids harvested at 216 h, only rare cells were in 
S phase (Figure 16B). 
4.3.2 Confocal immunofluorescence analysis 
Confocal immunofluorescence analysis showed that cells of spheroids that were cultured 
for 96h on agar and reverted to adhesion growth for 12 days contained vimentin 
intermediate filaments and stress fibers (Figure 17A). Cells of spheroids that were 
reverted to monolayer growth after 216h in agar displayed vimentin intermediate 
filaments but contained fewer stress fibers than spheroids collected at 96h (Figure 17B). 
Moreover, in cells of spheroids collected at 96h the vimentin and phalloidin staining 
colocalization was evident. 
4.3.3 Western blotting analysis 
Western blotting of α-SMA showed a decrease of the protein expression in spheroids 
collected at 96h and 216h and reverted to monolayer growth, with respect to monolayer 
myofibroblasts (Figure 18A). In particular, by densitometric analysis, this α-SMA 
reduction resulted particularly evident in extracts from spheroids collected at 216h and 
reverted to monolayer growth (Figure 18B). Furthermore, there was not a significant 
difference in the α-SMA levels between spheroids grown on agar and spheroids reverted 
to monolayer growth after 216h of three-dimensional culture. 
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4.4 Clusters and spheroids formed spontaneously  
Surprisingly, we found that, after 16 days, myofibroblasts from the skin of neck formed 
multicellular aggregates spontaneously, in the absence of agar, both in plastic 12-well 
plates or on glass coverslips (Figure 19). In particular, fibroblast clustering and 
spheroid formation were observed when the cell cultures remained 100% confluent     
for several days.  
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Chapter 5 
DISCUSSION 
 
The organization and physiological functions of multicellular organisms depend, among 
other factors, also on the cues from the connective tissue [36]. Fibroblasts are versatile 
and heterogeneous connective tissue cells which can acquire an activated and 
immunoregulatory phenotype, characterized by de novo expression of α-SMA and 
production of large amounts of COX-2 and proinflammatory cytokines [54, 2]. The 
activation of fibroblasts is a process controlled by continuous chemical and mechanical 
changes of the tissue microenvironment, which coincide with fibroblast to myofibroblast 
differentiation. Fibroblast-to-myofibroblast transition begins with the formation of the 
proto-myofibroblasts, containing stress fibres with β- and γ-cytoplasmic actins, and 
continues as they transform into myofibroblasts that present stress fibres with α-SMA [33]. 
α-SMA in stress fibres is the most commonly used molecular marker for myofibroblasts, 
and confers to these cells a stronger contractile function compared to proto-
myofibroblasts [22, 23]; instead the mesenchymal intermediate filament protein 
vimentin is a common marker for fibroblasts and myofibroblasts [108]. The 
myofibroblasts have been identified both in physiological conditions, where there is a 
necessity of mechanical force development for the rapid repair of damaged tissues, and in 
pathological conditions, such as fibrotic tissues and cancer [17]. To the best of my 
knowledge, this is the first study that combines these two factors, i.e. the use of primary 
fibroblasts and the cluster formation. In this study, we generated and analysed clusters, 
namely spheroids, of human primary cutaneous myofibroblasts. In comparison with the 
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established fibroblast clusters, the clusters of human primary fibroblasts better represent 
the stromal microenvironment.  
It is known that fibroblasts in vitro differentiate to myofibroblasts when cultured on high 
stiffness substrate, such as plastic dishes, in the presence of TGF-β [17]. Moreover, 
Santiago et al. demonstrated that fibroblasts, cultured on standard plastic plates, express 
α-SMA and differentiate to myofibroblasts [109]. 
The monolayer myofibroblasts used to generate spheroids also express COX-2 protein; in 
particular, it has been demonstrated by a previous study that COX-2 mRNA can be induced 
by fetal bovine serum [110]. Furthermore, it is known that the fetal bovine serum, present 
in monolayer and spheroids culture medium, can activate a transcriptional program related 
to physiology of wound repair in human primary cultured fibroblasts [110]. 
Myofibroblast aggregates and nodules are observed in wound healing and hypertrophic 
scars, respectively [36]. The aggregates of  fibroblasts were observed in the dermis at early 
stages of melanoma development, before metastasis formation. Moreover, there is a 
paracrine interaction between cancer cells and fibroblasts [76]. While at the end of wound 
healing, the activated fibroblasts undergo apoptotic cell death,  the same cells in vitro 
endure a programmed necrosis-like cell death, called nemosis, associated with COX-2 
induction and inflammatory response [2, 37]. During inflammation, wound healing and 
cancer, fibroblasts can lose their contacts to ECM. In these conditions several proteases, 
destroying ECM structure, liberate fibroblasts from ECM and trigger fibroblasts clusters 
formation [16]. These differences in biological cell characteristics and behaviour in vivo 
and in vitro represent a major hurdle in the studies of the activated fibroblast role in 
wound healing and cancer development. Aiming at overcoming this obstacle, we 
generated spheroids using and modifying the previously described hanging-drops and 
agarose-coated U-bottom well plates methods [96]. Such growth of fibroblasts can reflect 
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in vivo conditions, with the fibroblasts loosing their contact with the connective tissue, 
allowing the studies of myofibroblast turnover and contribution to organ remodelling. 
The present study demonstrated that human primary myofibroblasts from normal skin of 
neck can be induced to grow as multicellular aggregates, leading to myofibroblasts 
deactivation. Such approach to myofibroblast culture and analysis could represent an 
experimental model to study myofibroblast and tissue turnover.  The results of the study 
demonstrated that human primary myofibroblasts, if forced to grow as multicellular 
aggregates, preserve their mesenchymal characteristics and do not undergo apoptosis or 
nemosis. In particular, we showed that cell clustering did not lead to induction of COX-2 
protein that is associated with inflammatory response [38]. Furthermore, the significant 
α-SMA protein expression decrease in spheroids collected at different timepoints 
suggested that three-dimensional aggregation of myofibroblasts induced a deactivation 
process. Analysis of spheroids reverted to monolayer growth demonstrated that this 
deactivation process is reversible for spheroids collected at 96h and seems to be only 
partially reversible for spheroids collected at 216h. In particular, phalloidin staining 
showed that cells of spheroids collected at 216h developed stress fibres less extensively 
than spheroids collected at 96h. Moreover, the significant difference of α-SMA levels, 
detected between spheroids reverted to monolayer growth after 96h and 216h of three-
dimensional culture, confirms and explains the immunofluorescence analysis. 
Therefore, the morphological and molecular phenotype of spheroids collected at 216h 
resembles proto-myofibroblasts phenotype. The vimentin and phalloidin staining 
colocalization detected in spheroids at 96h is in agreement with previous studies 
showing that stress fibres contain vimentin [111] and that actin and vimentin filaments 
can interact directly [112]. 
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Paracrine epithelial-mesenchymal cell interactions play important role in both tissue 
repair and cancer progression [14, 105]¸ indeed activated fibroblasts support the 
proliferation and migration of normal and tumorigenic cells [2, 33]. In particular, 
previous studies showed that conditioned medium of activated fibroblasts triggers the 
proliferation and migration of non tumorigenic and tumorigenic cell lines, by increasing 
the expression of growth factors such as HGF/SF [105, 113, 114]. HGF/SF is a potent 
multifunctional growth factor produced by mesenchymal cells, with fibroblasts being its 
primary source [115]. HGF/SF has high affinity for the receptor tyrosine kinase c-Met [44]. 
In particular, HGF/SF induces Met signalling pathways regulating multiple cellular 
responses, such as migration, invasion, proliferation, branching morphogenesis, 
angiogenesis, mitogenesis and cancer cells tumorigenesis [116, 117, 118]. During wound 
healing, both migration and proliferation of keratinocytes are required for the re-
epithelization [119]. Proliferation and motility are also two key features for tumor 
progression. Motility is needed for the dissemination from the site of primary tumor, 
leading to invasive phenotype [47]. Cancer progression shows striking similarities with 
wound healing, since it also requires epithelial-mesenchymal interactions [45]. 
Furthermore, the tumor microenvironment, and in particular the role of activated 
fibroblasts, has been shown to be an important contributor to the tumor progression [13]. 
On this basis, we decided to investigate how inactivated fibroblasts within spheroids 
influence the behavior of the HaCat and HT1080 cells with regard to their proliferative and 
migratory response. Of note, HaCat and HT1080 are both c-Met positive cell lines [2, 120]. 
It is known that wound healing in HaCat cells is a combination of cell proliferation and 
migration [105]. Hence, these cell properties were evaluated in our study. First, we 
detected a cytostatic effect exerted by the spheroid-conditioned medium on both normal 
and cancer cell lines in MTT assay; this observation confirmed the deactivation of 
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myofibroblasts inside spheroids. Next, the wound healing assay demonstrated that 
spheroid-conditioned medium significantly delays the HaCat wound closure. Conversely, 
HT1080 cells treated with monolayer- or spheroid-conditioned medium displayed a similar 
migratory capability. Moreover, spheroid-conditioned medium seemed to inhibit the 
growth of HT1080 cells. Indeed, it is known that HT1080 proliferation and migratory 
capability can be differently regulated [121]. 
Our preliminary data showed that there are not differences in HGF/SF secretion levels 
between myofibroblasts forming monolayer and spheroids. Hence, these data call upon an 
in-depth examination of the paracrine interactions between spheroids and tumor cells. 
Indeed, it remains unknown whether the observed cytostatic and anti-migratory effect is 
due to toxic compounds present in spheroid-conditioned medium or it is associated with 
paracrine interactions mediated by other growth factors or by vesicles such as exosomes. 
Ki-67 is used as the marker of proliferation and it is expressed in cells committed to the 
progression through cell cycle and thus during late G1, S, G2, and M phases, but not in 
resting cells in G0 [122]. In this study, deactivation of myofibroblasts inside spheroids is 
further supported by Ki-67 staining analysis. In particular, immunohistochemical analysis 
of Ki-67 showed that after 48h of tridimensional culture there were no positive nuclei for 
Ki-67 and all cells were in G0 cell-cycle phase. Furthermore, the presence of positive nuclei 
for Ki-67 in spheroids collected after 24h suggests that fibroblasts do not stop proliferating 
abruptly during spheroids formation and that, as also shown by the time-dependent 
decrease of α-SMA protein levels, myofibroblasts deactivation is a step-by-step process.  
For many years, myofibroblast differentiation was considered irreversible process; 
therefore myofibroblasts were believed to be terminally-differentiated cells. As observed 
in several studies [37, 42, 123], at the end of wound healing, myofibroblasts undergo 
programmed cell death. To date it is not clear if myofibroblasts can acquire an in vivo 
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stable inactivated phenotype. In the present study, colorimetric evaluation of cell-cycle 
phases of spheroids reverted to monolayer growth demonstrated that fibroblasts 
maintained their proliferation capability within spheroids. Hence, the spheroid can be 
seen as a cell reservoir able, when needed, to liberate fibroblasts that can be re-activated. 
Similar conclusions emerge from other studies indicating that myofibroblasts can revert 
to a non-activated phenotype [123]. In particular, it was shown that murine 
myofibroblasts, originated from hepatic stellate cells, could revert to inactive phenotype 
during regression of liver fibrosis: these deactivated cells can be rapidly reactivated into 
myofibroblasts in response to fibrogenic stimuli [124]. 
It is intriguing that we observed spontaneous spheroid formation on high stiffness 
substrates represented by plastic or glass culture ware. Supposedly, this cluster formation 
could be a physiological and intrinsic feature of cutaneous myofibroblasts. 
Furtherrmore,it would be interesting to analyse these spontaneous spheroids and to 
compare them with spheroids generated on agar.  
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Chapter 6 
CONCLUSIONS 
 
During the last years, important advances have been made in the understanding of several 
aspects of myofibroblast biology. Fibroblasts are highly heterogeneous mesenchymal 
cells with the capability to acquire an activated phenotype. This activation is represented 
by their differentiation into myofibroblasts, a process that occurs in wound healing and 
cancer. In particular, once the wound is repaired, the number of activated fibroblasts 
decreases significantly as they undergo apoptosis. It is not known whether the 
myofibroblasts apoptosis is followed by tissue repopulation through fibroblasts from 
adjacent tissue [17]. Moreover, the hypothesis that activated fibroblasts can revert to an 
inactivated phenotype is controversial because they have been always believed 
terminally differentiated cells.  
This “dogma” is subverted by our data that support recent works sustaining that activated 
fibroblasts can revert to inactivated phenotype. As a matter of fact, we not only showed 
that in vitro human primary myofibroblasts from skin can be induced to grow as 
multicellular aggregates and do not die by apoptosis or nemosis, but we also documented 
that these cells undergo reversible deactivation during spheroids formation.  
The investigations on the reversibility of the myofibroblast differentiation are particularly 
important for the treatment of diseases involving myofibroblasts that do not undergo 
apoptotic cell death but remain constitutively activated. Our results support the use of 
3D cultures in biomedical research to bridge the gap between traditional cell cultures 
and in vivo settings in order to more clearly understand the inactivation mechanisms and 
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turnover of myofibroblasts. Accordingly, the approach introduced in this study could 
represent a tool for analysing the morphological and molecular mechanisms leading to 
myofibroblasts inactivation. Although further investigations are necessary, the current 
evidence shows that is conceivable that this experimental system might serve as a new 
important tool for studying several myofibroblast-related diseases, such as cancer, and 
could contribute to the development of new therapeutic strategies. One possible 
implementation of the deactivated fibroblast microenvironment present within spheroids 
is that its components could be able to inhibit tumor cell proliferation without 
inflammatory processes. In this perspective, in vivo studies should be employed in order 
to evaluate and validate this hypothesis. 
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